Cyteir Therapeutics, Inc.
CYTDelisted Mar 18, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001662244
Cyteir Therapeutics, Inc. was delisted on Mar 18, 2024; its insiders filed their last Form 4 on Mar 25, 2024; 38 institutions reported holding it in 13F filings for Q4 2023, worth $38.9M in total; no superinvestor held it.
13F holders, Q3 2022
Institutional positions in Cyteir Therapeutics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 37
- −8 vs. Q2 2022
- Shares held
- 18.0M
- −1.03M (−5.4%) vs. Q2 2022
- Total value
- $34.6M
- −$22.2M (−39.1%) vs. Q2 2022
- New holders
- 2
- 11 more added
- Sold out
- 10
- 14 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CYT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 4 | $11.2M |
| Q4 2023 | 38 | $38.9M |
| Q3 2023 | 41 | $46.3M |
| Q2 2023 | 39 | $41.7M |
| Q1 2023 | 32 | $23.9M |
| Q4 2022 | 30 | $28.5M |
| Q3 2022 | 37 | $34.6M |
| Q2 2022 | 45 | $56.8M |
| Q1 2022 | 52 | $83.8M |
| Q4 2021 | 48 | $253.4M |
| Q3 2021 | 38 | $344.1M |
| Q2 2021 | 33 | $352.6M |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Cyteir Therapeutics, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Novo Holdings A/S | 3,940,413 | $7.57M | 0.36% | −900,000−18.6% | Reduced |
| FMR LLC | 3,486,058 | $6.69M | 0.00% | −386,231−10.0% | Reduced |
| Baker Bros. Advisors LP | 2,643,640 | $5.08M | 0.03% | 00.0% | Unchanged |
| OUP Management Co., LLC | 2,469,572 | $4.74M | 7.38% | −5,000−0.2% | Reduced |
| Avidity Partners Management LP | 1,806,200 | $3.47M | 0.08% | −43,800−2.4% | Reduced |
| Caas Capital Management LP | 616,822 | $1.27M | 0.17% | +536,938+672.1% | Added |
| Newtyn Management, LLC | 654,112 | $1.26M | 0.28% | +47,864+7.9% | Added |
| Vanguard Group Inc | 584,492 | $1.12M | 0.00% | −27,106−4.4% | Reduced |
| Laurion Capital Management LP | 359,500 | $690.0K | 0.02% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 266,821 | $512.0K | 0.00% | −80,521−23.2% | Reduced |
| BlackRock Inc. | 196,912 | $376.0K | 0.00% | −4,592−2.3% | Reduced |
| RBF Capital, LLC | 152,382 | $293.0K | 0.03% | 00.0% | Unchanged |
| Evercore Wealth Management, LLC | 146,676 | $282.0K | 0.01% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 119,584 | $230.0K | 0.01% | +50,000+71.9% | Added |
| Millennium Management LLC | 119,234 | $229.0K | 0.00% | −7,915−6.2% | Reduced |
| Geode Capital Management, LLC | 113,628 | $218.0K | 0.00% | +36,041+46.5% | Added |
| Morgan Stanley | 69,334 | $133.0K | 0.00% | −146,039−67.8% | Reduced |
| UBS Group AG | 34,809 | $67.0K | 0.00% | +5,473+18.7% | Added |
| Two Sigma Advisers, LP | 28,300 | $54.0K | 0.00% | +5,900+26.3% | Added |
| State Street Corp | 23,853 | $46.0K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 21,007 | $40.0K | 0.00% | −5,361−20.3% | Reduced |
| Cannell Capital LLC | 19,684 | $38.0K | 0.01% | +15,793+405.9% | Added |
| ACT Capital Management, LLC | 15,000 | $29.0K | 0.04% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 13,093 | $25.0K | 0.00% | −11,269−46.3% | Reduced |
| Northern Trust Corp | 13,175 | $25.0K | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 11,796 | $23.0K | 0.00% | +522+4.6% | Added |
| Mariner, LLC | 11,852 | $23.0K | 0.00% | +11,852 | New |
| Goldman Sachs Group Inc | 11,670 | $22.0K | 0.00% | −12,769−52.2% | Reduced |
| Tower Research Capital LLC (TRC) | 5,859 | $11.0K | 0.00% | −141−2.4% | Reduced |
| Steward Partners Investment Advisory, LLC | 2,200 | $4.00K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 2,032 | $4.00K | 0.00% | +614+43.3% | Added |
| Lindbrook Capital, LLC | 2,006 | $4.00K | 0.00% | +2,000+33,333.3% | Added |
| Citigroup Inc | 669 | $1.00K | 0.00% | −266−28.4% | Reduced |
| Parallel Advisors, LLC | 464 | $1.00K | 0.00% | 00.0% | Unchanged |
| China Universal Asset Management Co., Ltd. | 332 | $1.00K | 0.00% | +332 | New |
| Wells Fargo & Company | 94 | $0 | 0.00% | +44+88.0% | Added |
| Daiwa Securities Group Inc. | 103 | $0 | 0.00% | 00.0% | Unchanged |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −58,529−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −17,557−100.0% | Sold out |
| Bailard, Inc. | 0 | $0 | 0.00% | −13,900−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −11,282−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −10,278−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −189−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Meeder Asset Management Inc | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| Ellevest, Inc. | 0 | $0 | 0.00% | −49−100.0% | Sold out |